troxerutin + porcine cerebroside

Compound Troxerutin and Porcine Cerebroside Injection is a fixed-dose combination therapeutic primarily utilized in China for the treatment of acute ischemic stroke and various cerebrovascular disorders. The formulation consists of **troxerutin**, a semi-synthetic flavonoid derivative of rutin, and **porcine cerebroside**, a mixture of glycosphingolipids extracted from pig brain tissue. Troxerutin acts as a vasoprotective agent that improves microcirculation by inhibiting platelet aggregation, reducing red blood cell deformability, and decreasing capillary permeability. Porcine cerebroside functions as a neurotrophic agent, providing essential lipids and signaling molecules that promote neuronal survival, metabolism, and repair following ischemic or traumatic injury. The combination is typically administered via intravenous infusion to mitigate neurological deficits and improve clinical recovery in the acute phase of stroke.

Brand names

Compound Troxerutin and Poreine Cerebroside Injection

Other names

Compound Troxerutin and Porcine Cerebroside InjectionCompound Troxerutin and Cerebroside InjectionTroxerutin and Porcine Cerebroside